Neos Therapeutics (NEOS) PT Lowered to $8 at BMO Capital

August 12, 2018 3:57 PM EDT Send to a Friend
BMO Capital analyst Gary Nachman lowered the price target on Neos ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login